Literature DB >> 11986485

Mortality associated with congenital syphilis in the United States, 1992-1998.

Deborah A Gust1, William C Levine, Michael E St Louis, Jim Braxton, Stuart M Berman.   

Abstract

OBJECTIVE: To summarize national trends in the incidence of congenital syphilis (CS) and associated mortality.
METHODS: We analyzed CS surveillance data reported to the Centers for Disease Control and Prevention by 50 states and the District of Columbia from 1992-1998.
RESULTS: From 1992-1998, 942 deaths, including 760 stillbirths, were reported among 14 627 cases of CS, yielding a case fatality ratio (stillborns and deaths/all cases) of 6.4%. Untreated, inadequately treated, or undocumented treatment of syphilis during pregnancy accounted for 87.4% of reported cases. Among CS cases, there was an inverse relationship between the number of prenatal care visits (0, 1-4, 5-9, >/=10) and risk of fatal outcome. Among deaths, 52% of deliveries occurred by 30 weeks' gestation. Among live born infants with CS, death occurred more often in infants for whom no radiograph or cerebrospinal fluid evaluation was reported. Although both cases and deaths from CS declined from 1992-1998, there was no significant change in the case fatality ratio.
CONCLUSION: Mortality associated with CS continues to be an important public health problem that will resurge if adult syphilis rates increase. Because a large proportion of deaths occur at low gestational age, earlier diagnosis and treatment of maternal syphilis may substantially reduce the case fatality ratio.

Entities:  

Mesh:

Year:  2002        PMID: 11986485     DOI: 10.1542/peds.109.5.e79

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Effectiveness of Prenatal Screening and Treatment to Prevent Congenital Syphilis, Louisiana and Florida, 2013-2014.

Authors:  James M Matthias; Mohammad M Rahman; Daniel R Newman; Thomas A Peterman
Journal:  Sex Transm Dis       Date:  2017-08       Impact factor: 2.830

2.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

3.  Congenital syphilis: still a serious, under-diagnosed threat for children in resource-poor countries.

Authors:  Carsten Krüger; Isaack Malleyeck
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

4.  Racial and ethnic disparities in prenatal syphilis screening among women with Medicaid-covered deliveries in Florida.

Authors:  Christina I Fowler; Norma I Gavin; E Kathleen Adams; Guoyu Tao; Monique Chireau
Journal:  Matern Child Health J       Date:  2007-07-18

5.  Maternal and paternal factors associated with congenital syphilis in Shenzhen, China: a prospective cohort study.

Authors:  J-B Qin; T-J Feng; T-B Yang; F-C Hong; L-N Lan; C-L Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-17       Impact factor: 3.267

Review 6.  Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality.

Authors:  Hannah Blencowe; Simon Cousens; Mary Kamb; Stuart Berman; Joy E Lawn
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

7.  Congenital Syphilis Masquerading as Leukemia.

Authors:  Tiffany Lee; Stephanie Bell; Jason Scimeme; Nizar Maraqa
Journal:  AJP Rep       Date:  2017-08-23

8.  Gaps in the implementation of antenatal syphilis detection and treatment in health facilities across sub-Saharan Africa.

Authors:  Mufaro Kanyangarara; Neff Walker; Ties Boerma
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 9.  Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis.

Authors:  Sarah J Hawkes; Gabriela B Gomez; Nathalie Broutet
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.